DeLoughery EP - Search Results

1

Review and Analysis of Mountaineering Accidents in the United States from 1947-2018.

DeLoughery EP, DeLoughery TG. DeLoughery EP, et al. High Alt Med Biol. 2022 Jun;23(2):114-118. doi: 10.1089/ham.2021.0085. Epub 2022 Mar 9. High Alt Med Biol. 2022. PMID: 35263173 Review.

2

A retrospective case control study of recombinant factor VIIa in patients with intracranial haemorrhage caused by trauma.

DeLoughery EP, Lenfesty B, DeLoughery TG. DeLoughery EP, et al. Among authors: deloughery tg. Br J Haematol. 2011 Mar;152(5):667-9. doi: 10.1111/j.1365-2141.2010.08437.x. Epub 2011 Jan 30. Br J Haematol. 2011. PMID: 21275948 Free article. Review. No abstract available.

3

The use of recombinant factor VIIa in warfarin patients with traumatic brain injury: a retrospective case-control study.

DeLoughery EP, Lenfesty B, DeLoughery TG. DeLoughery EP, et al. Among authors: deloughery tg. Blood Coagul Fibrinolysis. 2013 Apr;24(3):317-20. doi: 10.1097/MBC.0b013e32835cc16b. Blood Coagul Fibrinolysis. 2013. PMID: 23429251

4

Retrospective study of rFVIIa, 4-factor PCC, and a rFVIIa and 3-factor PCC combination in improving bleeding outcomes in the warfarin and non-warfarin patient.

DeLoughery E, Avery B, DeLoughery TG. DeLoughery E, et al. Am J Hematol. 2016 Jul;91(7):705-8. doi: 10.1002/ajh.24384. Epub 2016 May 11. Am J Hematol. 2016. PMID: 27074566 Free article.

5

Use of three procoagulants in improving bleeding outcomes in the warfarin patient with intracranial hemorrhage.

DeLoughery EP, DeLoughery TG. DeLoughery EP, et al. Among authors: deloughery tg. Blood Coagul Fibrinolysis. 2017 Dec;28(8):612-616. doi: 10.1097/MBC.0000000000000645. Blood Coagul Fibrinolysis. 2017. PMID: 28654426

6

Characteristics of fatal marine accidents.

DeLoughery EP. DeLoughery EP. Int Marit Health. 2022;73(3):115-116. doi: 10.5603/IMH.2022.0022. Int Marit Health. 2022. PMID: 36217975 Review.

7

The anticoagulated trauma patient in the wilderness.

DeLoughery EP, DeLoughery TG. DeLoughery EP, et al. Br J Haematol. 2024 Jul;205(1):387-389. doi: 10.1111/bjh.19550. Epub 2024 May 22. Br J Haematol. 2024. PMID: 38777750 No abstract available.

8

If the IMPROVE-IT Trial Was Positive, as Reported, Why Did the FDA Denied Expanded Approval for Ezetimibe and Simvastatin? An Explanation of the Tipping Point Analysis.

Deloughery EP, Prasad V. Deloughery EP, et al. J Gen Intern Med. 2018 Aug;33(8):1213-1214. doi: 10.1007/s11606-018-4498-3. Epub 2018 Jun 4. J Gen Intern Med. 2018. PMID: 29869138 Free PMC article. No abstract available.

9

Global prevalence of anemia among women of reproductive age, 2000-2019.

DeLoughery EP. DeLoughery EP. Eur J Haematol. 2024 Aug;113(2):253-256. doi: 10.1111/ejh.14227. Epub 2024 May 22. Eur J Haematol. 2024. PMID: 38775787

10

A comparative analysis of the safety profile of direct oral anticoagulants using the FDA adverse event reporting system.

DeLoughery EP, Shatzel JJ. DeLoughery EP, et al. Eur J Haematol. 2019 Jul;103(1):43-46. doi: 10.1111/ejh.13240. Epub 2019 May 6. Eur J Haematol. 2019. PMID: 31009121 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters